InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,792.80
(
0.00%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.42
(
-0.21%
)
Bitcoin
62,816.35
(
3.35%
)
Post# of 30387
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Gold Seeker

Send PM Follow Ignore
Followers 29
Posts 9421
Boards Moderated 0
Alias Born 04/30/2006

Gold Seeker

Re: VSLICK post# 22787

Sunday, 09/20/2009 6:18:16 PM

Sunday, September 20, 2009 6:18:16 PM

Post# of 30387
RECAF prostate test results with benign growths

68% sensitivity with 97% specificity when compared to men with benign prostate conditions. (32% false negatives)

Sensitivity is the ability of a test to detect existing cancers Specificity represents how well the test avoids false positives (no false positives = 100% specificity.)


Cancer patients vs. patients with benign prostate conditions:

STAGE(a) SENSITIVITY SPECIFICITY CANCER SAMPLES
Early (I+II or A+B) 68% 97% 84
III (C) 80% 97% 20
IV (D) 68% 97% 28

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up